Community health workers in clinical research at the example of a phase IIIb/ IV antimalarial drug trial conducted in five African countries
Standard
Community health workers in clinical research at the example of a phase IIIb/ IV antimalarial drug trial conducted in five African countries. / Groger, Mirjam; Lutete, Gaston Tona; Assi, Serge-Brice; Bigoga, Jude D; Ntamabyaliro, Nsengi Y; Arbe-Barnes, Sarah; Shin, Jangsik; Adegnika, Ayola A; Ntoumi, Francine; Kremsner, Peter G; Ramharter, Michael; Duparc, Stephan; Borghini-Fuhrer, Isabelle; Mombo-Ngoma, Ghyslain.
In: INT J INFECT DIS, Vol. 137, 12.2023, p. 114-117.Research output: SCORING: Contribution to journal › Short publication › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Community health workers in clinical research at the example of a phase IIIb/ IV antimalarial drug trial conducted in five African countries
AU - Groger, Mirjam
AU - Lutete, Gaston Tona
AU - Assi, Serge-Brice
AU - Bigoga, Jude D
AU - Ntamabyaliro, Nsengi Y
AU - Arbe-Barnes, Sarah
AU - Shin, Jangsik
AU - Adegnika, Ayola A
AU - Ntoumi, Francine
AU - Kremsner, Peter G
AU - Ramharter, Michael
AU - Duparc, Stephan
AU - Borghini-Fuhrer, Isabelle
AU - Mombo-Ngoma, Ghyslain
N1 - Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.
PY - 2023/12
Y1 - 2023/12
N2 - Global health, particularly in underserved settings can benefit immensely from well-trained community health workers (CHWs) supporting primary healthcare interventions. They can reduce morbidity and mortality of infectious diseases like malaria. Disease control programs can particularly benefit from a tight link between CHWs and communities and several studies have shown the benefit of the participation of non-facility-based CHWs in malaria control program activities for reducing malaria-related mortality in children. Because CHWs are often part of and trusted by served communities, they can also be an important resource to address challenges faced by their communities. Where post-marketing surveillance systems are underserved, they can relay important information about suspected safety signals and factors affecting therapeutic effectiveness in their communities. The CANTAM-Pyramax® trial was a phase IIIb/ IV cohort event monitoring study conducted at six centers in five African countries. To assess real-world effectiveness and safety of the anti-malarial pyronaridine-artesunate in 8560 malaria episodes, follow-up was not primarily conducted by medical staff but by specifically trained CHWs. This perspective paper discusses how the participation of a CHW workforce can be of benefit for effectiveness trials in limited-resource settings, using the example of the CANTAM-Pyramax trial.
AB - Global health, particularly in underserved settings can benefit immensely from well-trained community health workers (CHWs) supporting primary healthcare interventions. They can reduce morbidity and mortality of infectious diseases like malaria. Disease control programs can particularly benefit from a tight link between CHWs and communities and several studies have shown the benefit of the participation of non-facility-based CHWs in malaria control program activities for reducing malaria-related mortality in children. Because CHWs are often part of and trusted by served communities, they can also be an important resource to address challenges faced by their communities. Where post-marketing surveillance systems are underserved, they can relay important information about suspected safety signals and factors affecting therapeutic effectiveness in their communities. The CANTAM-Pyramax® trial was a phase IIIb/ IV cohort event monitoring study conducted at six centers in five African countries. To assess real-world effectiveness and safety of the anti-malarial pyronaridine-artesunate in 8560 malaria episodes, follow-up was not primarily conducted by medical staff but by specifically trained CHWs. This perspective paper discusses how the participation of a CHW workforce can be of benefit for effectiveness trials in limited-resource settings, using the example of the CANTAM-Pyramax trial.
KW - Child
KW - Humans
KW - Africa
KW - Antimalarials/therapeutic use
KW - Community Health Workers
KW - Malaria/drug therapy
U2 - 10.1016/j.ijid.2023.10.016
DO - 10.1016/j.ijid.2023.10.016
M3 - Short publication
C2 - 37871675
VL - 137
SP - 114
EP - 117
JO - INT J INFECT DIS
JF - INT J INFECT DIS
SN - 1201-9712
ER -